MDMA and psilocybin hub
Find out how to prescribe or get access to MDMA or psilocybin.
Authorised psychiatrists can access products containing 3,4‑methylenedioxy‑methamphetamine (MDMA) or psilocybin for specific mental health conditions from 1 July 2023.
MDMA can be used for the treatment of post-traumatic stress disorder.
Psilocybin can be used for treatment-resistant depression.
To access products containing MDMA or psilocybin, you must be a registered psychiatrist approved under the TGA's Authorised Prescriber scheme.